|
National Stock Number(NSN): 6505-00-995-1090 (6505009951090, 009951090)
| NIIN: |
00-995-1090 |
Item Name: |
CHYMOTRYPSIN FOR OPHTHALMIC SOLUTION |
INC: |
36236
|
| FSC: |
6505
|
Assignment Date: |
Apr-04-1967 |
CRIT: |
X |
IIG: |
36236 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-31-2022 |
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
3004.90.9285 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
ALPHA CHYMAR |
13964
|
BARNES-HIND INC SUB OF REVLON INC |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00053-2321-01 |
03884
|
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC |
H |
5 |
9 |
6 |
54 |
4 |
B |
|
|
|
|
|
NDC00077-2321-10 |
13964
|
BARNES-HIND INC SUB OF REVLON INC |
H |
3 |
9 |
6 |
54 |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DN |
S9M |
Y |
|
M |
U |
1 |
N |
$0.00 |
PG |
|
9L----- |
Oct-01-1987 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
750.000 UNITS CHYMOTRYPSIN ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
STERILE AND THINNER |
| CQCT |
PRIMARY CONTAINER TYPE |
PACKAGE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1 VIAL CONTAINING POWDER SUFFICIENT TO YIELD 750 UNITS CHYMOTRYPSIN AND 1 VIAL OF SODIUM CHLORIDE INJECTION 10 ML |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
6 |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G65V |
|
Apr-01-1991 |
0 |
0 |
|
|
54|65 |
54|65 |
|